VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas. PLoS One. 2015; 10(8):e0135101.
View in:
PubMed
subject areas
Antineoplastic Agents
Apoptosis
Cell Line, Tumor
Cell Survival
Cyclin-Dependent Kinase Inhibitor p21
Exons
Female
Gene Expression Regulation, Neoplastic
Humans
Imidazoles
Inhibitory Concentration 50
Introns
Mutation
Ovary
Piperazines
Proto-Oncogene Proteins c-mdm2
Sequence Analysis, DNA
Signal Transduction
Tumor Suppressor Protein p53
authors with profiles
JOANNE RICHARDS